AAV, mRNA & TIL Therapies — Three IND Applications Accepted on the Same Day
May 21, 2026 07:20
CST Updated
10:17
UgeneX
Ophthalmic Disease Treatment Drug Developer
Juncell Therapeutics
Solid Tumor Cell Therapy Developer
AviadoBio
Developer of Neurodegenerative Disease Therapies